The CRISPR protein (blue and pink) is attached to an RNA sequence (orange) that guides where to cut DNA (purple).
Science Photo Library / Alamy Stock Photo
The risk of developing many common conditions could be dramatically reduced by making dozens of changes to people’s genomes during the embryonic stage, a team of biologists and ethicists says. We don’t yet have the technology to do this safely, but we should start thinking about whether we should use it, they say.
However, their role has been attributed to other biologists, even today we know…
